Cargando…
Properdin Is a Key Player in Lysis of Red Blood Cells and Complement Activation on Endothelial Cells in Hemolytic Anemias Caused by Complement Dysregulation
The complement system alternative pathway (AP) can be activated excessively in inflammatory diseases, particularly when there is defective complement regulation. For instance, deficiency in complement regulators CD55 and CD59, leads to paroxysmal nocturnal hemoglobinuria (PNH), whereas Factor H muta...
Autores principales: | Chen, Jin Y., Galwankar, Neeti S., Emch, Heather N., Menon, Smrithi S., Cortes, Claudio, Thurman, Joshua M., Merrill, Samuel A., Brodsky, Robert A., Ferreira, Viviana P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7387411/ https://www.ncbi.nlm.nih.gov/pubmed/32793201 http://dx.doi.org/10.3389/fimmu.2020.01460 |
Ejemplares similares
-
A novel assay that characterizes properdin function shows neutrophil-derived properdin has a distinct oligomeric distribution
por: Moore, Sara R., et al.
Publicado: (2023) -
The role of properdin in complement-mediated renal diseases: a new player in complement-inhibiting therapy?
por: Michels, Marloes A. H. M., et al.
Publicado: (2018) -
QUANTITATIVE STUDIES ON THE PROPERDIN-COMPLEMENT SYSTEM
por: Leon, Myron A.
Publicado: (1956) -
Prognostic Value of Complement Properdin in Cancer
por: Mangogna, Alessandro, et al.
Publicado: (2021) -
Properdin and Factor H: Opposing Players on the Alternative Complement Pathway “See-Saw”
por: Kouser, Lubna, et al.
Publicado: (2013)